HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antioxidant supplementation in sepsis and systemic inflammatory response syndrome.

AbstractOBJECTIVE:
Summarize the current knowledge about oxidative stress-related organ dysfunction in inflammatory and septic conditions, and its potential prevention and treatment by antioxidants in critically ill patients, focusing on naturally occurring antioxidants and clinical trials.
STUDY SELECTION:
PubMed, MEDLINE, and personal database search.
SYNTHESIS:
Plasma concentrations of antioxidant micronutrients are depressed during critical illness and especially during sepsis. The causes of these low levels include losses with biological fluids, low intakes, dilution by resuscitation fluids, as well as systemic inflammatory response syndrome-mediated redistribution of micronutrients from plasma to tissues. Numerous clinical trials have been conducted, many of which have shown beneficial effects of supplementation. Interestingly, among the candidates, glutamine, glutathione, and selenium are linked with the potent glutathione peroxidase enzyme family at some stage of their synthesis and metabolism.
CONCLUSIONS:
Three antioxidant nutrients have demonstrated clinical benefits and reached level A evidence: a) selenium improves clinical outcome (infections, organ failure); b) glutamine reduces infectious complication in large-sized trials; and c) the association of eicosapentaenoic acid and micronutrients has significant anti-inflammatory effects. Other antioxidants are still on the clinical benchmark level, awaiting well-designed clinical trials.
AuthorsMette M Berger, René L Chioléro
JournalCritical care medicine (Crit Care Med) Vol. 35 Issue 9 Suppl Pg. S584-90 (Sep 2007) ISSN: 0090-3493 [Print] United States
PMID17713413 (Publication Type: Journal Article, Review)
Chemical References
  • Antioxidants
  • Biomarkers
  • Glutamine
  • Eicosapentaenoic Acid
  • Selenium
Topics
  • Animals
  • Antioxidants (administration & dosage, analysis, therapeutic use)
  • Biomarkers
  • Clinical Trials as Topic
  • Dose-Response Relationship, Drug
  • Eicosapentaenoic Acid (therapeutic use)
  • Glutamine (therapeutic use)
  • Humans
  • Oxidative Stress
  • Selenium (therapeutic use)
  • Sepsis (drug therapy, metabolism)
  • Systemic Inflammatory Response Syndrome (drug therapy, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: